Delivery Order SPE2DB20D1100-SPE2DB25FD9P3
- Not listed
- The Defense Logistics Agency (DLA) awarded a $2,881.36 delivery order to AmerisourceBergen Drug Corp for XOLAIR 150 mg/mL syringes, with an ultimate completion date of August 13, 2025. This firm fixed price contract, awarded July 23, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,241.54 delivery order to AmerisourceBergen Drug Corp for Xolair 150 mg/ml syringes, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a direct procurement of pharmaceutical supplies for federal medical needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,881.36 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/ml syringes, with an ultimate completion date of August 25, 2025. This competitive award, issued on August 4, 2025, utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,161.02 to AmerisourceBergen Drug Corp for the supply of XOLAIR 150 mg/ml syringes. The award was made on July 24, 2025, with an ultimate completion date of August 14, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor specializing in...
- The Defense Logistics Agency awarded a delivery order valued at $25,932.24 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/mL syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by August 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order valued at $4,322.04 to AmerisourceBergen Drug Corp for Xolair 150 mg/mL syringes, with an ultimate completion date of September 3, 2025. This non-competitive delivery order represents a firm fixed price transaction under AmerisourceBergen's existing pharmaceutical supply contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/mL syringes, valued at $2,161.02, with an ultimate completion date of August 22, 2025. This contract was awarded on August 1, 2025, under a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,644.08 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/mL syringes, with an ultimate completion date of August 27, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Xolair 150 mg/mL syringes, valued at $17,288.16. This firm fixed-price contract, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XOLAIR 150 mg/ml syringes valued at $2,881.36 with a firm fixed price contract type. The award was issued on July 18, 2025, with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. The contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under the company's existing...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9P3Delivery Order
The Defense Logistics Agency (DLA) awarded a $2,881.36 delivery order to AmerisourceBergen Drug Corp for Xolair 150 mg/ml syringes, with performance scheduled for completion by August 29, 2025. This competitively awarded, firm fixed-price delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX that runs through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations. AmerisourceBergen Drug Corp, a leading pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor supporting military and veteran healthcare systems. This delivery order is representative of the company's extensive portfolio of federal contract awards with DLA, which encompasses a wide range of pharmaceuticals, biologics, and medical supplies across multiple therapeutic domains. As a non-set-aside award, this contract reflects AmerisourceBergen's demonstrated capability to compete successfully in the federal marketplace and fulfill DLA's pharmaceutical supply chain requirements for military medical operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/8/25 |